A rare case of hypocalcemia induced by nilotinib
Chronic myelogenous leukemia (CML) is a myeloproliferative disorder characterized by increased proliferation of predominantly myeloid cells in the bone marrow and their accumulation in the peripheral blood. Nowadays, drugs known as tyrosine kinase inhibitors (TKIs) are the standard treatment for CML...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
VBZ
2017-03-01
|
| Series: | Endocrine Oncology and Metabolism |
| Subjects: | |
| Online Access: | http://eom.hdeo.eu/wp-content/uploads/2017/03/vol3-iss1-5Petric.pdf |